We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

125 hedge funds and large institutions have $606M invested in Amedisys in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 55 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

287% more call options, than puts

Call options by funds: $4.59M | Put options by funds: $1.19M

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

17% more capital invested

Capital invested by funds: $519M → $606M (+$86.6M)

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

1% more funds holding

Funds holding: 124125 (+1)

42% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 55

Holders
125
Holders Change
+1
Holders Change %
+0.81%
% of All Funds
3.63%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
20
Increased
32
Reduced
55
Closed
18
Calls
$4.59M
Puts
$1.19M
Net Calls
+$3.41M
Net Calls Change
-$342K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$3.9M -$78.2K -4,052 -2%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$3.71M +$199K +10,309 +6%
SFM
28
Systematic Financial Management
New Jersey
$3.52M +$817K +42,325 +32%
Charles Schwab
29
Charles Schwab
California
$3.5M -$18.1K -938 -0.5%
Deutsche Bank
30
Deutsche Bank
Germany
$2.97M -$1.33M -68,824 -32%
Two Sigma Investments
31
Two Sigma Investments
New York
$2.96M +$570K +29,569 +25%
Ameriprise
32
Ameriprise
Minnesota
$2.94M -$197K -10,218 -7%
Wells Fargo
33
Wells Fargo
California
$2.77M -$417K -21,622 -14%
OAM
34
Oxford Asset Management
United Kingdom
$2.46M -$2.12M -109,699 -48%
Acadian Asset Management
35
Acadian Asset Management
Massachusetts
$2.32M -$1.3M -67,457 -37%
BIM
36
BlackRock Investment Management
Delaware
$2.21M +$15.6K +809 +0.7%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$2.07M +$1.24M +64,400 +169%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$2.05M -$360K -18,670 -15%
SGH
39
Sivik Global Healthcare
Connecticut
$2.02M +$1.93M +100,000 New
CIBC World Market
40
CIBC World Market
Ontario, Canada
$1.77M +$1.7M +87,922 New
CS
41
Credit Suisse
Switzerland
$1.68M -$739K -38,328 -32%
SDIC
42
South Dakota Investment Council
South Dakota
$1.54M +$1.47M +76,400 New
New York State Teachers Retirement System (NYSTRS)
43
New York State Teachers Retirement System (NYSTRS)
New York
$1.45M +$24K +1,245 +2%
Prudential Financial
44
Prudential Financial
New Jersey
$1.44M -$41.3K -2,142 -3%
BC
45
Burney Company
Virginia
$1.37M +$66.6K +3,450 +5%
TA
46
Teachers Advisors
New York
$1.33M +$89.2K +4,621 +8%
RFC
47
Russell Frank Company
Washington
$1.29M +$1.23M +63,982 New
Point72 Asset Management
48
Point72 Asset Management
Connecticut
$1.26M +$1.2M +62,400 New
Public Sector Pension Investment Board (PSP Investments)
49
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.25M -$179K -9,300 -13%
U
50
UBS
Switzerland
$1.18M +$106K +5,480 +10%

AMED Hedge Fund Activity: Q3 2014 in Review

125 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2014, worth a combined $606M — up 17% from $519M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AMED positions and 18 closed out — a net gain of 2 holders — while 32 added to existing stakes and 55 trimmed.

The largest buyer was EverPoint Asset Management, opening a new position worth an estimated $9.65M. The largest seller was Fidelity Investments, cutting an estimated $12.4M.

  • 125 institutional investors held Amedisys (AMED) as of Q3 2014, up from 124 in Q2 2014.
  • Funds reported $606M of Amedisys stock for Q3 2014, up 17% quarter-over-quarter.
  • 20 funds opened new Amedisys positions in Q3 2014 and 18 closed out, a net change of +2 holders.
  • The largest Amedisys buyer in Q3 2014 was EverPoint Asset Management, an estimated $9.65M added.
  • The largest Amedisys seller in Q3 2014 was Fidelity Investments, an estimated $12.4M sold.

Based on aggregated 13F filings for Q3 2014.